News Releases

Month Year

Email Alerts

Apr 30, 2007

Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
Apr 25, 2007

Insmed Inc. Releases Investor Fact Sheet with Updates on Drug Development Progress
Mar 26, 2007

Insmed CEO Geoffrey Allan Testifies at Congressional Hearing
Mar 16, 2007

Insmed Announces Additional Information In Compliance With NASDAQ Rules
Mar 15, 2007

Insmed Inc. Reports Financial Results for Fourth Quarter and Twelve Months
Mar 10, 2007

Update: Insmed to Hold 2006 Q4 and Year End Earnings Results
Mar 9, 2007

Insmed to Hold 2006 Q4 and Year End Earnings Results
Mar 7, 2007

Insmed Announces Restructure, Settlement Ending IPLEX(TM) Patent Dispute
Mar 6, 2007

Insmed to Discuss Litigation Settlement with Tercica
Jan 10, 2007

Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
Dec 13, 2006

Insmed Announces Positive IPLEX(TM) Product Information At GRS-IGF Society Meeting in Kobe, Japan
Dec 7, 2006

Insmed to Host Litigation Update Conference Call
Dec 6, 2006

Insmed Patent Litigation Verdict Announced
Nov 21, 2006

Insmed to Present at Upcoming Investor Conference in NYC
Nov 3, 2006

Insmed Incorporated Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2006
Oct 31, 2006

Insmed Inc. to Announce 2006 Third Quarter Financial Results
Oct 31, 2006

Jody LoMenzo Named Director, Investor Relations and Corporate Communications
Oct 30, 2006

Insmed to Present at Upcoming Conferences
Oct 25, 2006

Former Amgen Manufacturing Executive Joins Insmed
Oct 24, 2006

Insmed Announces Addition of Top 25 Patent Lawyer to Litigation Team
Oct 17, 2006

Insmed to Present at the BIO Investor Forum Meeting
Oct 16, 2006

Insmed Sues Tercica for False Advertising
Oct 5, 2006

Insmed Provides Update Concerning Virginia Unfair Competition Litigation
Sep 6, 2006

Insmed to Present at the BioCentury NewsMakers in the Biotech Industry Conference
Aug 8, 2006

Insmed Incorporated Reports Financial Results for the First Half and Second Quarter Ended June 30, 2006

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation

Download

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

Our Global Company

Current Clinical Trials

Our Research Team

Our Global Company

Current Clinical Trials

Our Research Team

Footer